Patent · US Active

Triazolopyridine compounds and their use as ask inhibitors

US8263595B2 · kind B2 · utility

15Cited by
1References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 20, 2008
Grant dateSep 11, 2012
Priority date
Expiry dateAug 20, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to triazolopyridine compounds according to Formula (I), their use as medicament, for treating autoimmune disorders, inflammatory diseases, cardiovascular diseases and/or neurodegenerative diseases and a process for their preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.